Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 2, 2003, Pages 123-131

  Nair, S Asha ^a   Karunagaran, D ^a   Nair, M B ^b   Sudhakaran, P R ^c  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^b Doctors Diagn and Research Centre   (India)

^c UNIVERSITY OF KERALA   (India)

Author keywords

Cervical cancer; Immunohistochemistry; MMPs; TIMPs; Zymography

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; ZYMOGRAPHY;

EID: 0037312532     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0411-9     Document Type: Article

References (37)

1. Afzal S, Lalani EN, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M, Stamp GWH (1996) Matrix metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines. Lab Invest 74:406-421
2. Ambili M, Sudhakaran PR (1999) Modulation of neutral matrix metalloproteinases of involuting rat mammary gland by different cations and glycosaminoglycans. J Cell Biochem 73:218-226
3. Arenas F, Villa S, Solarza G, Raminez JL, de la Garza L (1995) Correlation between response to therapy and levels of metalloproteinases (MMPs) secreted in vitro in carcinoma of the cervix (CaCx). Proc Am Assoc Cancer Res 14:A817
4. Basbaum CB, Werb Z (1996) Focalized proteolysis spatial and temporal regulation of extracellular matrix at cell surface. Curr Opin Cell Biol 8:731-738
5. Birkedal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735
6. Brummer O, Bohmer G, Hollwitz B, Flemming P, Perry KU, Kuhnle H (2002) MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation - an immunohistochemical study. Gynecol Oncol 84:222-227
7. Campo E, Tavassoli FA, Charonis AS, Stetler-Stevenson WG, Liotta LA, Merino MJ (1992) Evaluation of basement membrane components and 72-kDa type IV collagenase in serous tumors of the ovary. Am J Pathol 6:500-507
8. Crawford HC, Matrisian LM (1995) Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14:234-245
9. Davidson B, Goldberg I, Kopolovic J, Lerner Geva L, Gotlieb WH, Weis B, Ben-Baruch G, Reich R (1999a) Expression of metalloproteinase-9 in squamous cell carcinoma of the uterine cervix - clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 72:380-386
10. Davidson B, Goldberg I, Kopolovic J, Lerner Geva L, Gotlieb WH, Weis B, Ben-Baruch G, Reich R (1999b) MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinomas - a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 73:372-382
11. De Clerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM (1992) Inhibition of invasion and metastasis in cell transfected with an inhibitor of metalloproteinases. Cancer Res 52:701-708
12. De Clerck YA, Shimada H, Taylor SM, Langley KE (1994) Matrix metalloproteinases and their inhibitors in tumor progression. Ann N Y Acad Sci 732:222-232
13. De'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Griogioni WG (1991) Augmentation of type-IV collagenase, laminin receptor, and Ki 67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 4:239-246
14. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM (1993) Tissue inhibitor of metalloproteinases (TIMP, akaEPA): structure, control of expression and biological function. Pharmacol Ther 59:329-341
15. Gilles C, Polette M, Pielta J, Manaut C, Thompson EW, Birembaut P, Foidart JM (1996) High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 65:209-213
16. Greene L, Wang M, Xiao G, Liu YE, Shi YE (1996) Loss of expression of TIMP-4 a novel human tissue inhibitor of metalloproteinase in human breast cancer progression. Proc Am Assoc Cancer Res 37:91
17. Hoyhtya M, Fridman R, Komarck D, Porter-Jordan K, Stetler Stevenson WJ, Liotta LA, Liang CM (1994) Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissue with monoclonal antibodies. Int J Cancer 56:500-505
18. Iwasaki M, Nishikawa A, Fujimoto T, Akutgawa N, Manase K, Endo T, Yoshida K, Maekawa R, Yoshioka T, Kudo R (2002) Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines. Gynecol Oncol 85:103-107
19. Iwata H, Iwase H, Koboyashi S (1995) Invasion and metastasis of breast cancer matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPS). Biotherapy 9/ 11:1359-1366
20. Kato Y, Yamashita T, Ishikawa M (2002) Relationship between expression of matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol Rep 9:565-569
21. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M (1993) Expression of matrix metalloproteinase 2 related to lymph node metastasis of oral squamous cell carcinoma: a clinicopathologic study. Am J Clin Pathol 99:18-23
22. Levy A, Cioce V, Sobel ME, Garbisa S, Griogioni WF, Liotta LA (1991) Increased expression of the 72 kDa type IV collagenase in human colonic adenocarcinoma. Cancer Res 51:439-444
23. Monteagudo C, Merino MJ, SanJuan J, Liotta LA, Stetler Stevenson WJ (1990) Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol 136:585-592
24. Moser PL, Kieback DG, Hefler L, Tempfer C, Neunteufel W, Gitsch G (1999) Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage 1B cervical cancer. Anticancer Res 19:4391-4393
25. Nair AS, Nair MB, Jayaprakash PG, Rajalekshmi TN, Nair MK, Pillai MR (1997) The basement membrane and tumor progression in the uterine cervix. Gen Diag Pathol 142:297-303
26. Nair AS, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR (1998) ras and c-myc oncoproteins during tumor progression in the uterine cervix. Tumori 84:583-588
27. Naylor MS, Stamp GWH, Davies B, Balkwill FR (1994) Expression and activity of MMPs and their regulators in ovarian cancer. Int J Cancer 58:50-56
28. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffrey RE, Longcroft J, Roger L, Stamp GWH (1992) Stromal expression of 72kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141:389-396
29. Pyke C, Ralfkiaer E, Tryggvason K, Dano K (1993) Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142:359-365
30. Takemura M, Azuma C, Kimura T, Kanai T, Saji F, Tanizawa O (1994) Type-IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues. Int J Gynecol Obstet 46:303-309
31. Talvensaari-Mattila A, Apaja-Sarkkinen M, Hoyhtya M, Westerlund A, Puistola U, Turpeenniemi-Hujanen T (1999) Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial differentiation. Gynecol Oncol 72:306-311
32. Tamakoshi K, Kikawa F, Nawa A, Ishikawa H, Mizuno K, Tamakoshi A, Yamagata S, Suganuma N, Tomoda Y (1995) Characterization of extracellular matrix-degrading proteinase and its inhibitors in gynecological cancer tissue with clinically different metastatic form. Cancer 76:2561-2571
33. Thomas GT, Lewis MP, Speight PM (1999) Matrix metalloproteinases and oral cancer. Oral Oncol 35:227-233
34. Toki N, Kaku T, Tsukamoto N, Marsumura M, Saito T, Kamura T, Matsuyama T, Nakano H (1990) Distribution of basement membrane antigens in the uterine cervical adenocarcinomas: an immunohistochemical study. Gynecol Oncol 38:17-21
35. Tsuboi R, Yamaguchi T, Nakao H, Ogawa H, Ishihara K (1988) Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelium, and seborrheic keratosis. J Invest Dermatol 90:869-872
36. Visscher DW, Hoyhtya M, Ottosen SK, Liang CM, Sarkar FH, Crissman JD, Fridman R (1994) Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 59:339-344
37. Werb Z (1997) ECM and cell surface proteolysis regulating cellular ecology. Cell 91:439-442